NTLA — Intellia Therapeutics, Inc. stock price, charts and financials

QT21Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.14
-0.12-0.98%
OverviewShort InterestFilings
NTLAQT21Intellia Therapeutics, Inc.·NASDAQ
12.14-0.98%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 08, 20268-KCurrent report
Sep 04, 20268-KCurrent report
Aug 24, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 24, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 20268-KCurrent report
#1 / 25 of 348
Page
▼
/ 14